Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relative Bioavailability of Prifetristat Differing in Particle Size Distribution in Healthy Participants
NCT07721402Phase 1Recruiting
- Sponsor
- Pfizer
- Start
- Jul 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (2 arms), sponsored by Pfizer. Primary endpoints: Area under the Plasma Concentration-Time profile from time 0 to extrapolated infinite time and Maximum Observed Plasma Concentration. Started Jul 2026; status: recruiting.
Beyond the preview
Go deeper on NCT07721402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07721402.